The two peptides have separate FDA concerns: FDA flagged CJC-1295 for limited clinical data and serious adverse events including increased heart rate and systemic vasodilatory reaction
J Clin Endocrinol Metab (2019) 104:552939
J Membr Biol 69:112 Mulcahy RT, Bailey HH, Gipp JJ (1995) Transfection of complementary DNAs for the heavy and light subunits of human gamma-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan
It may cause anemia, characterized by fatigue, weakness, and pale skin due to a lack of healthy red blood cells
Get a personalized treatment plan (if Rxd) based on your goals, progress, and lifestyle plus refill reminders, in-app check-ins, and real human support every step of the way
Ongoing monitoring ensures safety and appropriate patient selection